Coleman, Diamond Foods, Safe Bulkers: U.S. Equity Movers

Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 4 p.m. in New York.

Banks advanced after JPMorgan Chase & Co. (JPM) raised its dividend and said it would buy back more shares, with no objection from the Federal Reserve. JPMorgan (JPM US) rose 7 percent to $43.39 for the biggest gain in the Dow Jones Industrial Average. Citigroup Inc. (C) increased 6.3 percent to $36.45; Wells Fargo & Co. (WFC) gained 5.8 percent to $33.33; Bank of America Corp. (BAC US) advanced 6.3 percent to $8.49.

Metlife Inc. (MET) , the insurer waiting for a ruling from the Federal Reserve on its capital plan, rose 4.7 percent to $39.46.

Alliant Techsystems Inc. (ATK) fell 6.2 percent, the most since Aug. 10, to $54.03. The world’s largest ammunition maker was cut to “underperform” from “sector perform” at RBC Capital Markets. The company earlier forecast 2013 earnings per share of no more than $6.30, less than the average analyst estimate of $7.17.

BioCryst Pharmaceuticals Inc. (BCRX) decreased 5.2 percent, the most since Feb. 14, to $5.26. The drugmaker will initiate a process at the U.S. Patent & Trademark Office to correct an “apparent error,” according to a regulatory filing. BioCryst said that a patent for a hepatitis C inhibitor it discovered was issued to Biota Holdings Ltd. (BTA AU).

Carmike Cinemas Inc. (CKEC) gained 17 percent, the most since Aug. 9, to $10.67. The fourth-largest U.S. theater chain posted fourth-quarter revenue that exceeded the average analyst projection, data compiled by Bloomberg show.

Coleman Cable Inc. (CCIX) dropped the most in the Russell 2000 Index, retreating 20 percent to $10.35. The maker of electrical wires and cables said that, excluding some items, it expects to earn 27 cents a share in the first quarter. Analysts, on average, estimated 32 cents, according to a Bloomberg Survey.

Cornerstone Therapeutics Inc. (CRTX) increased 8.8 percent, the most since Dec. 14, to $6.17. The biopharmaceutical company specializing in respiratory treatments had a new drug application for its hyponatremia product CRTX 080 accepted by the Food and Drug Administration.

Diamond Foods Inc. (DMND) rose 4.8 percent, the most since Feb. 15, to $25.70. The seller of Emerald snack nuts and Pop Secret popcorn retained Dean Bradley Osborne Partners LLC as financial adviser to strengthen its balance sheet as a planned earnings restatement threatens to violate some of its debt agreements.

FactSet Research Systems Inc. (FDS) advanced 8.6 percent, the most since February 2009, to $98.66. The Norwalk, Connecticut-based financial-data supplier reported second- quarter profit and sales that exceeded analysts’ estimates.

Great Wolf Resorts Inc. (WOLF) surged 27 percent, the most since September 2008, to $5.32. The operator of indoor water parks agreed to be bought by Apollo Global Management for $5 a share, or about $703 million.

Majesco Entertainment Co. (COOL) dropped 14 percent, the most since Jan. 18, to $2.56. The video game publisher said fiscal 2012 adjusted earnings may be 25 cents to 35 cents a share. Analysts project 35 cents a share on average, data compiled by Bloomberg show.

Midas Inc. (MDS) surged 27 percent, the most since December 2008, to $11.44. The operator of car-service shops agreed to be acquired by tire supplier TBC Corp. for $11.50 per share.

Safe Bulkers Inc. (SB) tumbled 9.1 percent, the most since Aug. 8, to $6.50. The provider of marine dry-bulk transportation services said it’s offering to sell 5 million shares at $6.50 each.

Urban Outfitters Inc. (URBN) fell 5.3 percent, the most in the Standard & Poor’s 500 Index, to $27.95. The operator of its namesake, Anthropologie and Free People brands reported fourth-quarter earnings that missed the average analyst estimate.

Vaalco Energy Inc. (EGY) increased 16 percent, the most since Feb. 15, to $8.69. The Houston-based oil company posted fourth-quarter adjusted earnings of 15 cents a share, missing the average of analyst estimates compiled by Bloomberg by 46 percent.

To contact the reporter on this story: Whitney Kisling in New York at

To contact the editor responsible for this story: Nick Baker at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.